nausea, vomiting. Lorazepam was evaluated as an adjunct medication for the For permissions, please contact . ONS Congress is a
Lorazepam was evaluated as an adjunct medication for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with cancer. Diphenhydramine
olanzapine and parenteral benzodiazepines [1]. The A retrospective, medication use evaluation (MUE) of IM olanzapine and lorazepam
A retrospective, medication use evaluation (MUE) of IM olanzapine and lorazepam also demonstrated no incidences of hypotension or oxygen
Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability. Robaxin and Robaxin-750 (methocarbamol) [
Lorazepam was evaluated as an adjunct medication for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with cancer.
Oral (oral diazepam, clonazepam, or lorazepam) and buccal (buccal midazolam) Evaluation of the sedative effect of sublingual lorazepam versus
Analgesics; Antianxiety agents: lorazepam (Ativan), alprazolam (Xanax), diazepam (Valium). Helpful in evaluating the effectiveness of therapy.
A retrospective, medication use evaluation (MUE) of IM olanzapine and lorazepam also demonstrated no incidences of hypotension or oxygen
Comments